---
title: 'Armand P, Zinzani PL, Lee HJ, etÂ al. Five-year follow-up of KEYNOTE-087: pembrolizumab
  monotherapy for relapsed/refractory classical Hodgkin lymphoma. Blood. 2023;142(10):878-886'
date: '2024-07-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39023865/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240719181246&v=2.18.0.post9+e462414
source: Blood
description: No ...
disable_comments: true
---
No ...